Biofidelity is a pioneer in the genomic technology space, and the UK-based company’s mission is to unlock the benefits of precision medicine for cancer patients. Its revolutionary technologies can be used for early detection, precise diagnosis and routine monitoring applications in oncology.
Barnaby Balmforth, CEO at Biofidelity, explained how working closely with LGC Clinical Diagnostics ensures the high quality, bespoke next generation sequencing (NGS) reference materials that the company needs to validate its technology for translation into clinical practice.
To read the Customer Case Study in its entirety, click here or on the button below.
To learn how your lab can work with SeraCare, email CDx-Sales@lgcgroup.com, or call +1 508-244-6400.